Inpart

End-to-end platform for R&D partnerships

Employees
51–200
Business Model
SaaS
Website
inpart.io
Total Funding
$71.7M
Last Round
$70.0M Growth EquityJan 2023
Rounds
3

About

Inpart is the trusted partner for biopharma and science partnering, providing a technology platform used by more than 6,500 organizations, including 45 of the world's top 50 pharma companies, 25 of the top 25 global R&D-intensive firms, and over 200 leading universities. Its core products include Connect, a matchmaking platform connecting industry professionals, academic institutions, and investors, and Deal, a partnering CRM built specifically for managing biopharma alliances and collaborations. Inpart also owns Labiotech, a life-science digital media subsidiary reaching over 100,000 industry professionals monthly.

Summary

Inpart is an EdTech company. It has raised $71.7M in total across 3 rounds, most recently a $70.0M Growth Equity round in Jan 2023. Investors include Northern Powerhouse Investment Fund (Mercia Ventures), The Carlyle Group and NextStage AM.

Tech & App Stack

8 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Growth EquityGrowth EquityJan 2023
$70.0M

Sign up to see all 3 rounds

Seed through Growth Equity — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Inpart on Indexed.vc
<a href="https://indexed.vc/companies/inpart"><img src="https://indexed.vc/api/badge/company/inpart" alt="Inpart on Indexed.vc" width="260" height="76" /></a>